Skip to main content
Key Specialties
Anesthesiology Cardiology Dermatology Diabetology Endocrinology Gastroenterology and Hepatology General Medicine Geriatrics Hematology Infectious Diseases Internal Medicine Nephrology Neurology Obstetrics and Gynecology Oncology Ophthalmology Pediatrics Psychiatry Radiology Respiratory Medicine Rheumatology Surgery Urology
Congress Coverage
ASH 2024 Annual Meeting 2024 ESMO Congress 2024 ERS Congress 2024 EASD Congress 2024 ESC Congress 2024 EAN Congress 2024 ASCO Annual Meeting 2024 ACC Congress
Clinical Collections
Advances in Alzheimer’s
Webinar

Keynote webinar | Spotlight on adolescent vaping

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Watch the on-demand webinar
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in:

12-05-2024 | Anal Cancer | Colorectal Cancer

Updates on the Version 9 American Joint Committee on Cancer Staging System for Anal Cancer

Authors: Lauren M. Janczewski, MD, MS, Elliot A. Asare, MD, MS, Karyn A. Goodman, MD, MS

Published in: Annals of Surgical Oncology | Issue 7/2024

Login to get access

Excerpt

Since its first edition was published in 1977, the American Joint Committee on Cancer (AJCC) has remained the authority on cancer staging for nearly all malignancies, including anal cancer.1 Importantly, the AJCC staging system has created a common language for cancer risk stratification, allowing cancer care providers across the world to effectively communicate about tumor burden and treatment paradigms. Not only does the AJCC staging system provide prognostic information regarding the estimated survival for patients with cancer but it also plays a vital part in cancer research, including eligibility for practice-changing clinical trials. Additionally, AJCC cancer staging is a critical tool in cancer epidemiology and population health, as the structured framework and consistency allows for tracking of trends and comparison of data over time and across the globe. The AJCC staging system undergoes periodic revisions in order to ensure that the contemporary staging definitions reflect evolving practice patterns and survival outcomes for each primary disease site. …
Literature
1.
Amin MB, Greene FL, Edge SB, et al. The Eighth Edition AJCC Cancer Staging Manual Continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin. 2017;67(2):93–9.CrossRefPubMed
2.
3.
Leichman L, Nigro N, Vaitkevicius VK, et al. Cancer of the anal canal. Model for preoperative adjuvant combined modality therapy. Am J Med. 1985;78(2):211–25.CrossRefPubMed
4.
Goodman KA, MJ Gollub, C Eng, et al. AJCC Cancer Staging System Version 9: Anus. 2020.
5.
Janczewski LM, Browner A, Cotler J, et al. Data-driven optimization of version 9 American Joint Committee on Cancer staging system for anal cancer. Cancer. 2024;130(9):1702–10.CrossRefPubMed
6.
Janczewski LM, Faski J, Nelson H, et al. Survival outcomes used to generate version 9 American Joint Committee on Cancer staging system for anal cancer. CA Cancer J Clin. 2023;73(5):516–23.CrossRefPubMed
7.
Mistrangelo M, Pelosi E, Bello M, et al. Role of positron emission tomography-computed tomography in the management of anal cancer. Int J Radiat Oncol Biol Phys. 2012;84(1):66–72.CrossRefPubMed
8.
Golia Pernicka JS, Sheedy SP, Ernst RD, Minsky BD, Ganeshan D, Rauch GM. MR staging of anal cancer: what the radiologist needs to know. Abdom Radiol (NY). 2019;44(11):3726–39.CrossRefPubMed
9.
Glynne-Jones R, Nilsson PJ, Aschele C, et al. Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Radiother Oncol. 2014;111(3):330–9.CrossRefPubMed
10.
Mistrangelo M, Pelosi E, Bello M, et al. Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of inguinal node metastases in patients with anal cancer. Int J Radiat Oncol Biol Phys. 2010;77(1):73–8.CrossRefPubMed
11.
Cotter SE, Grigsby PW, Siegel BA, et al. FDG-PET/CT in the evaluation of anal carcinoma. Int J Radiat Oncol Biol Phys. 2006;65(3):720–5.CrossRefPubMed
12.
Gunderson LL, Moughan J, Ajani JA, et al. Anal carcinoma: impact of TN category of disease on survival, disease relapse, and colostomy failure in US Gastrointestinal Intergroup RTOG 98–11 phase 3 trial. Int J Radiat Oncol Biol Phys. 2013;87(4):638–45.CrossRefPubMedPubMedCentral
13.
Gunderson LL, Winter KA, Ajani JA, et al. Long-term update of US GI intergroup RTOG 98–11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin. J Clin Oncol. 2012;30(35):4344–51.CrossRefPubMedPubMedCentral
14.
James RD, Glynne-Jones R, Meadows HM, et al. Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 x 2 factorial trial. Lancet Oncol. 2013;14(6):516–24.CrossRefPubMed
15.
Salama JK, Mell LK, Schomas DA, et al. Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience. J Clin Oncol. 2007;25(29):4581–6.CrossRefPubMed
16.
Palefsky JM, Lee JY, Jay N, et al. Treatment of anal high-grade squamous intraepithelial lesions to prevent anal cancer. N Engl J Med. 2022;386(24):2273–82.CrossRefPubMedPubMedCentral
17.
NCCN Clinical Practice Guidelines in Oncology Version 2.2021.
Metadata
Title
Updates on the Version 9 American Joint Committee on Cancer Staging System for Anal Cancer
Authors
Lauren M. Janczewski, MD, MS
Elliot A. Asare, MD, MS
Karyn A. Goodman, MD, MS
Publication date
12-05-2024
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 7/2024
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-024-15412-8

Other articles of this Issue 7/2024

Reply to: Letter to Editor Regarding Article “A Machine Learning Approach to Predict Postoperative Pancreatic Fistula after Pancreaticoduodenectomy Using Only Preoperatively Known Data” by Yang, Yanfei et al.

  • Pancreatic Tumors

Reply to: Colorectal Cancer Screening and Social Vulnerability Index: Impact of COVID-19 Pandemic

How to Do It: Supracarinal Approach of the Left Recurrent Laryngeal Nerve Area for Total Mediastinal Lymphadenectomy During Thoracoscopic Esophagectomy

Beta Probe for Radioguided Surgery in Gastrointestinal Neuroendocrine Tumors: A Move in the Right Direction

Reply to Letter to Editor Regarding Article “C-Reactive Protein/Albumin Ratio is an Independent Risk Factor for Recurrence and Survival Following Curative Resection of Stage I–III Colorectal Cancer in Older Patients”

ASO Visual Abstract: Improved Postoperative Pain Management Outcomes After Implementation of Enhanced Recovery After Surgery (ERAS) Protocol for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC)

  • ASO Visual Abstract
SPONSORED

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Sponsored by:
  • Viatris
Developed by: Springer Healthcare
Watch now
Video
Image Credits